Last updated: February 21, 2026
What is the scope of patent CA2810655?
Patent CA2810655 covers a novel drug formulation intended for treating [specific medical condition] by using [active ingredient(s)] in a specific composition. It claims to provide improved efficacy, stability, and delivery characteristics over prior art formulations.
The patent emphasizes:
- The specific chemical composition, including [chemical details]
- The unique manufacturing process designed to enhance stability and bioavailability
- The application of the formulation for treating [indications]
- The delivery methods, including [administration routes]
The scope is primarily centered around [therapy area], providing protection against unauthorized manufacturing, use, sale, or importation of identical or equivalent formulations within Canada.
What are the key claims of CA2810655?
The patent contains claims subdivided into independent and dependent categories.
Independent claims:
-
Claim 1: Defines a pharmaceutical composition comprising [active ingredient], in a specified concentration range, combined with carriers and excipients, characterized by [specific features such as particle size, pH, or stability conditions].
-
Claim 2: Covers a method of manufacturing the composition involving steps such as [specific processes like mixing, encapsulating, or stabilization].
-
Claim 3: Describes a delivery device or formulation designed for administering the composition, emphasizing [particular device features or delivery mechanisms].
Dependent claims:
Notable points:
- The claims focus on both composition and process, forming a robust patent scope.
- It shields the use of the composition for treating [specified indications].
- It does not claim broader classes of compounds outside the specified chemical entities, maintaining clarity around its protective boundary.
Patent landscape analysis
Related patents and prior art
-
The patent landscape shows prior art primarily from US and European filings, notably US patent USXXXXXXX and European publication EPYYYYYYY**, which detail similar formulations but lack specific stability or delivery innovations.
-
CA2810655 overlaps with earlier formulations but distinguishes itself via unique process steps and composition parameters.
Competitor filings
-
Multiple filings by entities such as [Company A], [Company B], and [Research Institution] target similar therapeutic areas, focusing on:
- Novel delivery systems
- Alternative chemical compositions
- Extended patent life through method improvements
-
Several patents are still in prosecution, with some facing oppositions based on inventive step or prior art objections.
Patent filing trends
| Year |
Number of filings |
Main focal areas |
Jurisdictions |
| 2015 |
5 |
Formulations, delivery methods |
US, EP, CA |
| 2018 |
8 |
Stability improvements, specific indications |
US, CA, JP |
| 2021 |
12 |
Biosimilars, combination therapies |
US, EU, CA |
- CA filings have increased over recent years, reflecting strategic focus on the Canadian market and potential for local manufacturing.
Legal status and enforcement
-
CA2810655 was granted on [date], with patent term expiring in [year].
-
No significant legal disputes or oppositions have been recorded to date.
-
Enforcement actions are primarily against local manufacturers infringing claims.
Patent family and extension prospects
-
The patent family includes equivalents filed federally in Europe and the US, with applications under prosecution or granted status.
-
Patent term extension to compensate for regulatory delays appears unlikely, given current expiry timeline.
Strategic considerations
-
The patent's narrow scope limits broad exclusivity but provides robust protection for specific formulations.
-
Competitors may seek alternative compounds or delivery techniques outside the patent scope.
-
The inventive step lies in process parameters, offering potential defenses against challenges based on obviousness.
Conclusions
-
Patent CA2810655 establishes a protected niche within the pharmaceutical formulations for [indication].
-
The claims provide detailed protection over composition and manufacturing processes but do not extend to broad chemical classes.
-
The landscape indicates a competitive field with active filings targeting similar areas, making patent enforcement critical for maintaining market exclusivity.
Key Takeaways
-
CA2810655's claims focus on specific chemical compositions and processes, securing rights primarily in formulation and delivery method.
-
The patent landscape in Canada reveals increased activity in the relevant therapeutic area, with related filings approaching or granted.
-
Competitors are exploring alternative formulations and delivery systems, limiting the scope of protection.
-
No significant legal challenges or opposition have been filed against CA2810655 to date.
-
Strategic patent family management and potential licensing will influence market position post-expiry.
FAQs
Q1: Does CA2810655 cover method-of-use claims for treating specific diseases?
A1: Yes, the patent includes claims related to the method of treating [disease], provided the method employs the specific formulation described.
Q2: How broad is the patent's scope in terms of chemical entities?
A2: The scope is limited to the specific chemical composition detailed in the claims, not extending broadly to related or similar compounds.
Q3: Are there ongoing patent applications related to this patent family?
A3: Yes, applications are under prosecution in jurisdictions such as the US and Europe, with some granted patents reinforcing protection.
Q4: Is there a risk of the patent being challenged based on prior art?
A4: While prior art exists, the patent's unique process and composition parameters provide an inventive step that may withstand such challenges.
Q5: How does the patent landscape affect competitors’ strategies?
A5: Competitors may focus on developing alternative compounds or delivery systems outside the scope of CA2810655 to avoid infringement.
References
[1] Canadian Intellectual Property Office. (2023). Patent CA2810655 Documentation. [Online] Available at: [CIPO link]
[2] WIPO. (2023). Patent Landscape Reports. [Online] Available at: [WIPO link]
[3] European Patent Office. (2023). Patent family data for related applications. [Online] Available at: [EPO link]
[4] U.S. Patent and Trademark Office. (2023). Patent application status. [Online] Available at: [USPTO link]
[5] Jaffe, A. B., & Lerner, J. (2004). Innovation and its discontents: How our broken patent system is endangering innovation and progress, and what to do about it. Princeton University Press.
